ArticleFrontiers in cardiovascular medicine2021

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study.

Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.